BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9519615)

  • 1. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN; Kumar S; Jain S; Bhattacharya SN
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic prospects for paucibacillary leprosy.
    Katoch K
    Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
    [No Abstract]   [Full Text] [Related]  

  • 3. Relapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
    Shetty VP; Antia NH
    Lepr Rev; 1997 Jun; 68(2):162-6. PubMed ID: 9217356
    [No Abstract]   [Full Text] [Related]  

  • 4. Dapsone syndrome: an incomplete form.
    Jaswal R; Thami GP; Kanwar AJ
    Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
    [No Abstract]   [Full Text] [Related]  

  • 5. Facial reversal reaction: a dermatological emergency.
    Marzano AV; Tosi D; Cusini M; Nunzi E; Massone C; Crosti C
    J Dermatol; 2012 Feb; 39(2):203-5. PubMed ID: 21951390
    [No Abstract]   [Full Text] [Related]  

  • 6. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline tuberculoid leprosy developing in a pure neuritic case.
    Porichha D; Mahapatra DC
    Indian J Lepr; 1991; 63(2):235-7. PubMed ID: 1783794
    [No Abstract]   [Full Text] [Related]  

  • 8. Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
    Asz-Sigall D; López-García L; Neme-Yunes Y; Yuen-Palos R; Vega-Memije ME; Arenas R
    Int J Dermatol; 2008 Oct; 47(10):1084-6. PubMed ID: 18986365
    [No Abstract]   [Full Text] [Related]  

  • 9. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leprosy in a preschool child--a case report.
    Arora SK
    J Indian Med Assoc; 2007 Mar; 105(3):140. PubMed ID: 17824468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
    Ganapati R; Pai VV; Shroff HJ; Gandewar K
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):264-6. PubMed ID: 9251604
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary hyperpigmented palmar lesion: a rare presentation of borderline tuberculoid leprosy.
    Grover S; Singh G; Dash K
    Indian J Lepr; 1997; 69(2):191-3. PubMed ID: 9290973
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
    Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of borderline tuberculoid Hansen's disease with tuberculosis verrucosa cutis in a child--a rare case.
    Ravindra K; Sugareddy ; Ramachander T
    Indian J Lepr; 2010; 82(2):91-3. PubMed ID: 21434512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
    Lockwood DN
    Lepr Rev; 1997 Dec; 68(4):299-300. PubMed ID: 9503865
    [No Abstract]   [Full Text] [Related]  

  • 16. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I; Cartel JL; Grosset JH
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose treatment for single lesion leprosy; histopathological observations.
    Shinde A; Khopkar U; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):328-30. PubMed ID: 11221099
    [No Abstract]   [Full Text] [Related]  

  • 18. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S; Reddy R
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract]   [Full Text] [Related]  

  • 19. Lupus vulgaris and borderline tuberculoid leprosy: an interesting co-occurrence.
    Rao GR; Sandhya S; Sridevi M; Amareswar A; Narayana BL;
    Indian J Dermatol Venereol Leprol; 2011; 77(1):111. PubMed ID: 21220903
    [No Abstract]   [Full Text] [Related]  

  • 20. Leprosy in HIV infection: a study of three cases.
    Rath N; Kar HK
    Indian J Lepr; 2003; 75(4):355-9. PubMed ID: 15242274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.